A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
Clinical trial NCT06161441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06161441
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2026-08-24
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.